2010•Unpublished venueRequires access

Effect of magnesium isoglycyrrhizinate on abnormal hepatic function after chemotherapy:60 cases report

Jiejun Wang

Open publisher page 0 citations

Abstract

Objective:To observe the effect of magnesium isoglycyrrhizinate on abnormal hepatic function after chemotherapy.Methods:A total of 60 cases with abnormal hepatic function after chemotherapy were divided into 2 groups:treatment group with 250 mL intravenous drip of magnesium isoglycyrrhizinate 200 mg and 5% glucose injection for 10 d,and control group without liver-protective drugs.Hepatic function indexes including alanine aminotransferase(ALT),aspartate aminotransferase(AST)and total bilirubin(TbiL)were observed and compared.Results:The improvement of hepatic function was more significant in treatment group(P0.05).Conclusions:With little side-effect and high security,magnesium isoglycyrrhizinate can markedly improve hepatic function indexes,and shorten the course.

About this research paper

What this paper is about

Objective:To observe the effect of magnesium isoglycyrrhizinate on abnormal hepatic function after chemotherapy.Methods:A total of 60 cases with abnormal hepatic function after chemotherapy were divided into 2 groups:treatment group with 250 mL intravenous drip of magnesium isoglycyrrhizinate 200 mg and 5% glucose injection for 10 d,and control group without liver-protective drugs.Hepatic function indexes including alanine aminotransferase(ALT),aspartate aminotransferase(AST)and total bilirubin(TbiL)were observed and compared.Results:The improvement of hepatic function was more significant in treatment group(P0.05).Conclusions:With little side-effect and high security,magnesium isoglycyrrhizinate can markedly improve hepatic function indexes,and shorten the course.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To observe the effect of magnesium isoglycyrrhizinate on abnormal hepatic function after chemotherapy.Methods:A total of 60 cases with abnormal hepatic function after chemotherapy were divided into 2 groups:treatment group with 250 mL intravenous drip of magnesium isoglycyrrhizinate 200 mg and 5% glucose injection for 10 d,and control group without liver-protective drugs.Hepatic function indexes including alanine aminotransferase(ALT),aspartate aminotransferase(AST)and total bilirubin(TbiL)were observed and compared.Results:The improvement of hepatic function was more significant in treatment group(P0.05).Conclusions:With little side-effect and high security,magnesium isoglycyrrhizinate can markedly improve hepatic function indexes,and shorten the course.

Key concepts: Medicine, Hepatic function, Liver function, Bilirubin, Chemotherapy, Gastroenterology, Internal medicine, Alanine aminotransferase

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of magnesium isoglycyrrhizinate on abnormal hepatic function after chemotherapy:60 cases report — Research Paper | ScholarLens